SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-14 |
| Reported value | $131,488,918 |
| Positions | 25 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| MAPLIGHT THERAPEUTICS INC | MPLT | COM | $34,809,708 | 971,253 |
| LB PHARMACEUTICALS INC | LBRX | COM SHS | $20,467,973 | 630,657 |
| EVOMMUNE INC | EVMN | COM SHS | $19,151,315 | 1,441,032 |
| CYBIN INC | HELP | COM NEW | $6,525,537 | 987,222 |
| INCYTE CORP | INCY | COM | $6,092,193 | 53,742 |
| RHYTHM PHARMACEUTICALS INC | RYTM | COM | $5,453,794 | 49,120 |
| BEONE MEDICINES LTD | ONC | SPONSORED ADS | $4,480,298 | 15,722 |
| OCULIS HOLDING AG | OCS | ORDINARY SHARES | $4,168,837 | 300,565 |
| ASCENDIS PHARMA A/S | ASND | ORD SHS | $3,627,392 | 13,600 |
| REVOLUTION MEDICINES INC | RVMD | COM | $3,605,702 | 19,253 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.